Recruitment

Recruitment Status
Completed

Inclusion Criteria

Birth weight ≥2500 g and ≤4500 g
Healthy newborn infant
Infant is ≤14 days old on day of enrollment
...
Birth weight ≥2500 g and ≤4500 g
Healthy newborn infant
Infant is ≤14 days old on day of enrollment
Having obtained his/her parents'/legal representative's informed consent
Singleton birth
Gestational age ≥37 weeks (full term infants)

Exclusion Criteria

Parents not expected to comply with the protocol during the period of study participation.
Having any significant pre-natal and/or post-natal disease and/or congenital illness or malformation that may affect normal growth.
Re-hospitalization for more than 2 days in the first 14 days of life.
...
Parents not expected to comply with the protocol during the period of study participation.
Having any significant pre-natal and/or post-natal disease and/or congenital illness or malformation that may affect normal growth.
Re-hospitalization for more than 2 days in the first 14 days of life.
Infants currently participating in another trial
Infant undergoing antibiotic therapy.

Summary

Conditions
Infant Growth
Type
Interventional
Design
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Participation Requirements

Age
Younger than 14 years
Gender
Both males and females

Inclusion Criteria

Birth weight ≥2500 g and ≤4500 g
Healthy newborn infant
Infant is ≤14 days old on day of enrollment
...
Birth weight ≥2500 g and ≤4500 g
Healthy newborn infant
Infant is ≤14 days old on day of enrollment
Having obtained his/her parents'/legal representative's informed consent
Singleton birth
Gestational age ≥37 weeks (full term infants)

Exclusion Criteria

Parents not expected to comply with the protocol during the period of study participation.
Having any significant pre-natal and/or post-natal disease and/or congenital illness or malformation that may affect normal growth.
Re-hospitalization for more than 2 days in the first 14 days of life.
...
Parents not expected to comply with the protocol during the period of study participation.
Having any significant pre-natal and/or post-natal disease and/or congenital illness or malformation that may affect normal growth.
Re-hospitalization for more than 2 days in the first 14 days of life.
Infants currently participating in another trial
Infant undergoing antibiotic therapy.

Tracking Information

NCT #
NCT02111837
Collaborators
Not Provided
Investigators
  • Principal Investigator: Claude Billeaud, MD Hôpital des enfants, CHU Pellegrin, Bordeaux, France
  • Claude Billeaud, MD Hôpital des enfants, CHU Pellegrin, Bordeaux, France
About Us
Innovation
Privacy
Terms
Copyright
Get Well Soon © Copyright 2023